In the May/June 2020 issue of Practical Pain Management, the authors conducted a retrospective case review of 35 patients treated with Low Dose Naltrexone for chronic pain. They found that 46% reported a 50% or better improvement in their pain or chose to continue LDN...
As a compounding pharmacy, we're continuously exploring various medications’ values in multiple disease states, not just the indicated usage. Off-label use is the creative field of medicine where we can expand our collective ability to solve your healthcare problems. Specifically, we have been exploring how...
A 2018 Dartmouth-Hitchcock Medical Center study concluded that “based on current reports of numerous benefits and an excellent safety profile, clinical use of Low Dose Naltrexone or ‘LDN’ may be seen as a reasonable option in patients with fibromyalgia or irritable bowel disease.” This 18 page...